June 2016 - Bioscience Americas

June 2016

Colombia is an Important Destination for Medical Tourism

Colombia is experiencing a significant increase in medical tourism. Hospital in Medellín is ranked among the best in Latin America. Foreigners coming to Colombia for medical treatment in 2015 spent approximately $316 million, up from $134 million in 2012. Bogotá and Medellín are major destinations on the global medical tourism map. Costs in Colombia can be significantly less than costs in the U.S. For example, a heart bypass surgery in the U.S. that may cost $80,000 or more costs only [...]

Breast Cancer Cells Flushed Out of Hiding

Scientists have uncovered a molecular key that breast cancer cells use to gain access to bone marrow, where they hide from the effects chemotherapy or hormonal therapies. The results of the mouse studies are published in Science Translational Medicine. New findings could prevent women who survive breast cancer from facing a relapse years later. Not only have the researchers managed to prevent the cells from using this escape tactic, but they have succeeded in flushing the cells out into the [...]

Investors Can’t Get Enough of Colombia

Many investors have been stampeding out of emerging-market bonds, but they’re falling in love with Colombia. Investors have poured $622.5 million into Colombia’s bond market since the start of the year, the biggest inflow into any emerging-market country so far in 2014, according to fund flow tracker EPFR Global. Colombia has seen significantly more inflows than its peers, as the only other emerging economies with bond inflows this year — South Korea, Poland and Greece – all have had less [...]

Bioscience Americas Creates New Sports Marketing Division

Bioscience Americas, LLC announced today the creation of a new division entitled Bioscience High Performance (BHP). Complementing the Company’s existing business model providing stem cell treatments for autoimmune diseases and rejuvenation therapies primarily through medical tourism, the new division will focus on working with professional athletes and sports teams in the United States, Canada, and Latin America. Bioscience Americas CEO Eric Stoffers said that BHP is poised to serve what he characterized as a vast market to treat athletic injuries [...]